This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Mei Xu - Innovator in Antibody Development
Introduction
Mei Xu is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work focuses on innovative solutions for medical treatments.
Latest Patents
Mei Xu holds a patent for "Antibodies against growth differentiation factor 15 and uses thereof." This patent includes monoclonal antibodies that bind to the human Growth Differentiation Factor 15 protein, also known as GDF15. The patent outlines pharmaceutical compositions and methods of treatment that utilize these antibodies.
Career Highlights
Mei Xu is currently associated with Novartis AG, a leading global healthcare company. Her role involves research and development in the field of antibody therapies, contributing to advancements in medical science.
Collaborations
Throughout her career, Mei Xu has collaborated with notable colleagues, including Hong M Chen and Rajiv Chopra. These partnerships have enhanced her research and expanded the impact of her innovations.
Conclusion
Mei Xu's work in antibody development exemplifies the importance of innovation in biotechnology. Her contributions continue to pave the way for new treatments and therapies in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile